OGT Expands Custom NGS Cancer Panel Content and Readies Enhanced Software for Release
The expanded SureSeq myPanel next-generation sequencing custom cancer panel now covers 120 fully optimized cancer-related genes.
Read MorePosted by Steve Halasey | Jul 19, 2018 | Software |
The expanded SureSeq myPanel next-generation sequencing custom cancer panel now covers 120 fully optimized cancer-related genes.
Read MorePosted by Melissa Mayer | Jul 12, 2018 | Tubes |
This month’s issue features an HIV self-test from Atomo Diagnostics, microscopy software from Basler, and a fume hoods from Hemco.
Read MorePosted by Elaine Sanchez Wilson | Apr 19, 2018 | Disease States |
Progress and challenges are on the way to a blood-based assay for PD-L1.
Read MorePosted by Elaine Sanchez Wilson | Jan 17, 2018 | Leukemia, Standards |
SeraCare Life Sciences has expanded its suite of clinical genomics development, validation, and quality control tools with the launch of Seraseq myeloid DNA and myeloid RNA fusion reference materials.
Read MorePosted by Elaine Sanchez Wilson | Jan 3, 2018 | Leukemia |
Bio-Rad Laboratories has introduced the QXDx BCR-ABL %IS kit, a CE-marked digital polymerase chain reaction test that can monitor the molecular response to therapy of patients with chronic myeloid leukemia.
Read More